FundedIQ
Biopharma

SiccaNova Therapeutics: Funding, Investors & Team (Sep 2026)

SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.

www.siccanova.com Tsukuba, Japan Founded 2022
Total raised
$7.9M
Rounds
1
Latest
Series A
Sep 2026

SiccaNova Therapeutics has raised $7.9M across 1 funding round on record, the most recent a Series A of $7.9M announced in Sep 2026.

That round is above the $4.3M median round size for Japan companies tracked on FundedIQ over the last two years.

SiccaNova Therapeutics Company Profile and Key Stats

Total funding raised
$7.9M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$7.9M in Sep 2026
Founded
2022
Headquarters
Tsukuba, Japan
Investors on record
6
5 named below

Latest funding round on record: Sep 2026.

SiccaNova Therapeutics Funding Rounds

Date
Round
Amount
Series A
$7.9M

SiccaNova Therapeutics Investors

JIC Venture Growth Investments MPower Partners Tohoku University Venture Partners Joyo Capital Partners 77 Partners

6 investors are recorded in total; the 5 named above are those the record identifies.

SiccaNova Therapeutics Funding in Context

Segment
Companies
Median round
332
$4.3M
8,378
$15M

SiccaNova Therapeutics' latest round of $7.9M is above the median round in Japan. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like SiccaNova Therapeutics in Biopharma and Tsukuba

Companies Similar to SiccaNova Therapeutics

Tikva Allocell is a biotechnology company that specializes in next-gen cell therapies.

Series A $8.0M

PeopleX is an HR solutions platform that offers an AI interviewer, skills development, a meeting tool, and…

Series A $34.0M

Power Laser is a tech company that develops cutting-edge power laser technology and applications for various…

Series A $7.5M

Metro Weather is a technology company that develops and manufactures Doppler LIDAR to visualize atmospheric…

Series B $9.4M

SUNSHIKI is a green tech startup that offers seaweed technology to develop seaweed-based products.

Pre-Seed $500k

Paytner is a finance firm that provides factoring services to support freelance people's funding.

Series D $14.4M

KG Motors is an automotive firm that manufactures electric vehicles that can be moved comfortably and safely…

Undisclosed round $2.9M

ByFood connects travelers with Japan’s best food experiences and restaurants while donating meals to children…

Series B $8.4M

Tellus Global is a company focused on creating new businesses using satellite data, AI, and software…

Seed $5.6M

Atierra develops microalgae systems that convert carbon dioxide into oils for sustainable aviation fuel and…

Pre-Seed $380k

Beff is a company that focuses on Global AI and battery development.

Series A $2.8M

ElleThermo is an energy company that specializes in the manufacturing and sales of renewable energy…

Series A $5.2M

SiccaNova Therapeutics Funding FAQs

What does SiccaNova Therapeutics do?

SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.

How much funding has SiccaNova Therapeutics raised?

SiccaNova Therapeutics has raised $7.9M across 1 round on record. The most recent is a Series A of $7.9M announced in Sep 2026.

When did SiccaNova Therapeutics last raise funding?

SiccaNova Therapeutics' most recent funding round on record is a Series A of $7.9M, announced in Sep 2026.

Who has invested in SiccaNova Therapeutics?

Investors on record for SiccaNova Therapeutics include JIC Venture Growth Investments, MPower Partners, Tohoku University Venture Partners, Joyo Capital Partners, 77 Partners. FundedIQ records 6 investors in total.

Where is SiccaNova Therapeutics headquartered?

SiccaNova Therapeutics is based in Tsukuba, Japan.

When was SiccaNova Therapeutics founded?

SiccaNova Therapeutics was founded in 2022.

About FundedIQ's SiccaNova Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SiccaNova Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.